Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-11-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for Nexturn Bioscience, which is a comprehensive financial report covering the period from January 1, 2023, to June 30, 2023. It includes detailed company information, business descriptions, and financial data. Although it is labeled as a '정정신고' (Correction Report), it is a substantive financial filing that provides the corrected content of the semi-annual report itself, not just an announcement of its publication. Therefore, it is classified as an Interim/Quarterly Report. H1 2023
2023-11-13 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds (Refixing). This type of disclosure relates to changes in the company's capital structure and financial instruments. Since it specifically details the adjustment of conversion prices for existing debt, it falls under the category of capital and financing updates.
2023-11-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage (specifically due to a conversion price adjustment of convertible bonds) by a major shareholder (Sangsangin Savings Bank) in Nexturn Bioscience. This falls under the category of Major Shareholding Notification (MRQ).
2023-11-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on the Status of Large-Scale Shareholdings' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity acquires a significant stake (typically 5% or more) in a listed company. This specific document details the shareholding status of Baro Saving Bank in Nexturn Bioscience. In the context of global financial reporting, these filings are classified as Major Shareholding Notifications.
2023-10-31 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) regarding a 'Single Sale/Supply Contract' amendment. It details changes to delivery schedules and payment terms for a CNC machine supply contract. Since this is a specific regulatory disclosure regarding a material business contract and does not fit into categories like financial reports, M&A, or governance, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2023-10-31 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from Nexturn Bio regarding the adjustment of the conversion price of convertible bonds (CB). It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2023-10-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.